Olympic Steel Inc. (ZEUS) Drops 7.87% on January 19

Equities Staff |

Olympic Steel Inc. (ZEUS) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 7.87% to $8.54, a loss of $-0.73 per share. Starting at an opening price of $9.28 a share, the stock traded between $8.40 and $9.28 over the course of the trading day. Volume was 67,406 shares over 591 trades, against an average daily volume of 86,913 shares and a total float of 11 million.

The losses send Olympic Steel Inc. down to a market cap of $93.96 million. In the last year, Olympic Steel Inc. has traded between $20.93 and $6.40, and its 50-day SMA is currently $10.68 and 200-day SMA is $13.07.

Olympic Steel Inc is a metal services center in U.S. The Company is engaged in the processing and distribution of carbon, coated, aluminum and stainless steel, flat-rolled coil, sheet and plate products and tubular and pipe products.

Olympic Steel Inc. is based out of Highland Hills, OH and has some 1,714 employees. Its CEO is Michael D. Siegal.

For a complete fundamental analysis analysis of Olympic Steel Inc., check out Equities.com’s Stock Valuation Analysis report for ZEUS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…